Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment
The U.S. Department of Defense (DOD) has awarded UF startup Ology Bioservices, Inc. (Ology), a wholly-owned subsidiary of Resilience, a contract valued as much as $250 million for manufacturing development of a monoclonal antibody as a medical countermeasure (MCM) to botulinum neurotoxins (BoNT).
Resilience Turns to Harvard for Biologics Manufacturing Tech, Inks 5-Year R&D Pact
Resilience, a company developing technologies that overcome the challenges of manufacturing complex biological medicines, is turning to Harvard University to find some of those new solutions.
AavantiBio and Resilience Announce Strategic Collaboration for Gene Therapy Development and Manufacturing
UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and National Resilience, Inc. (Resilience), a company building the world’s most advanced biopharmaceutical manufacturing ecosystem and who recently acquired UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, announced a strategic collaboration to support the development and manufacturing of AavantiBio’s pipeline of therapies, including its lead program in Friedreich’s Ataxia (FA).
Resilience To Get $164M for Site Expansion
Resilience, a manufacturing and technology company that recently acquired Ology Bioservices, will receive $164M to update and expand a site in Ontario.
‘One Billion Doses On Day One’: Vaccine Company Claims World-Changing Innovation
Curious about what motivates the company that just acquired UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices? Anger at the length of time it is taking to get vaccines to fight Covid. This story in Forbes is a picture of Resilience, a new player in the town of Alachua.
Resilience Acquires Biologics Manufacturing Company Ology Bioservices
Resilience, a company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired Ology Bioservices, Inc., a privately held company that also specializes in biologic drug substance manufacturing from early-stage through commercial products.
